Dismiss Modal

Children's of Alabama has had 54 residency program graduates since its ASHP-Accredited status was granted in 1997. Eight of these residency graduates have chosen to continue their training in PGY2 programs in specialty pediatric practice areas. Almost all our residency graduates are currently in pediatric pharmacy practice; however, a few past graduates are employed in adult institutions, academia, and even in industry. Three graduates are now residency program directors at their pediatric practice sites.

We are proud that many of our residency graduates choose to remain at Children's post-residency or return later in their careers to work with us again. 22 past residents are currently employed full-time at Children's, with another 5 working part-time. In addition, one past resident is on the faculty at Samford University and maintains a practice site at Children's. Many of these staff members are actively involved in training our new residents each year!

Recent Residency Graduates

Listed below are our most recent graduates, their school of pharmacy, their immediate post-PGY1 position and institution, and their residency research project.


Lindsay Allison
University of Saint Joseph School of Pharmacy 
Multispecialty Pharmacist, Yale New Haven Children’s Hospital
Antibiotic use in Staphylcoccal Scalded Skin Syndrome

Savannah Jones
Samford University
PGY2 pediatrics, Samford McWhorter School of Pharmacy
Evaluating Melatonin Use in Pediatric Patients

Gracelyn “Gracie” Wade
Auburn University
Pediatric pharmacist, Baptist Health System
Vitamin D deficiency in renal transplant patients: efficacy of replacement


Rachael (Jaszczenski) Savage
Medical College of Wisconsin
Clinical pharmacist, Children’s Wisconsin
Melatonin Appropriateness in Pediatric Intensive Care Units

Taylor Mathwich
Auburn University
Staff pharmacist, Children’s of Alabama
Ketorolac Efficacy in Post-Operative Patients Less than 2 Years of Age

April (Jones) Smith
Samford University
Staff pharmacist, Children’s of Alabama
Assessment of Dexmedetomidine Withdrawal in a Pediatric Cardiovascular Intensive Care Unit


Charles “Chad” Bowman
University of Mississippi
Pediatric clinical/operational pharmacist, Rush University Medical Center
Evaluating Vancomycin Exposure in Pediatric Patients Using an Area Under the Curve (AUC)

Rachel (Elston) Murphy
Auburn University
Clinical Pharmacist, Huntsville Women’s and Children’s Hospital
Evaluation of Micafungin Prophylaxis in Pediatric Patients with Leukemia

Jessica (Grunwald) Gurley
University of Arkansas
Clinical Pharmacy Specialist, Dell Children’s Hospital
Safety of Intravenous Ketorolac for Post-Operative Pain Management in Children Less than 2 years of age

2019 - 2020

Christian “Hubbs” Bottcher
Auburn University
Clinical Pharmacist, Huntsville Women’s and Children’s Hospital
Benefits of a pharmacy-led medication reconciliation compared to current standard of practice in a pediatric teaching hospital

Jerrica Eaton
University of Mississippi
PGY2 pediatric oncology, Children’s Hospital of Seattle
Evaluation of the management of gram-negative bacteremia in a pediatric hospital

Cathryn Schrader
University of Georgia
Staff pharmacist, Children’s of Alabama
Vitamin D deficiency in renal transplant recipients: incidence and efficacy of replacement therapy


Leanna Barker
Auburn University
Pediatric clinical pharmacist, Ochsner LSU Health
Evaluation of the current management of pediatric osteomyelitis

Joshua Branstetter
University of Florida
PGY2 pediatric critical care, LeBonheur Children’s Hospital
Efficacy and tolerability of ceftaroline compared to vancomycin for the treatment of methicillin-resistant staphylococcus aureus associated cystic fibrosis exacerbations in children

Madeleine King
Auburn University
PGY2 pediatric oncology, St. Jude Children’s Research Hospital
Efficacy and cost savings of fixed dose rasburicase for tumor lysis syndrome management in pediatric oncology patients


Mary Claire (Estess) Blackmon
Auburn University
Staff pharmacist, Children’s of Alabama
Mycophenolate mofetil pharmacokinetics and early immune events after pediatric kidney transplant

Kayley (Liuzzo) Carney
University of the Sciences in Philadelphia
PGY2 pediatric critical care and infectious disease, Children’s Hospital Colorado
Fish oil-based lipid emulsion’s role in transitioning pediatric patients from plant-based to combination plant and fish-oil based lipid emulsion

Andrew Smelser
University of Mississippi
Clinical pharmacist, University of Iowa Children’s Hospital
Evaluation of acute kidney injury in pediatric cystic fibrosis patients, a single-center experience


Anna (Arthur) Daniels
Southern Illinois University
Critical care pharmacist, LeBonheur Children’s Hospital
Evaluation of time to maximum opioid usage during vaso-occlusive sickle cell crises in a pediatric inpatient hospital setting

Hannah (Coulson) Denslow
Virginia Commonwealth University
Staff pharmacist, Children’s Hospital of the King’s Daughters
Impact of duration of valganciclovir prophylaxis on the incidence of cytomegalovirus reactivation and disease in pediatric kidney transplantation recipients

Anna Curl
Samford University
Clinical Pharmacist, St. Luke’s Children’s Hospital
Outcomes of outpatient parenteral antimicrobial therapy in a pediatric hospital